Search clinical trials for: Glucose-Insulin-Potassium

Total 7752 results

Novo Nordisk A/S

Completed

Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Poland, United Kingdom, Spain, Denmark, France, Netherlands, Austria, Hungary, Russian Federation, Germany, Turkey, Italy, Bulgaria, Romania, Belgium, Switzerland, Slovenia, Czech Republic
Novo Nordisk A/S

Completed

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects

Healthy | Diabetes

Japan
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

South Africa
Hospices Civils de Lyon

Terminated

Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study. (CONTROLING)

Critical Illness

France
Eli Lilly and Company

Completed

Assessment of Mealtime Bolus Insulin Behavior

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Novo Nordisk A/S

Completed

Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Diabetes Mellitus, Type 2 | Diabetes

Slovenia
Jagdeesh Ullal
Wake Forest University Health Sciences

Active, not recruiting

Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes

Cystic Fibrosis-related Diabetes

United States
Sanofi

Completed

Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy (Insuman-C25-CN)

Type 2 Diabetes Mellitus

China
Novo Nordisk A/S

Completed

Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment (EasyMix)

Diabetes Mellitus, Type 2 | Diabetes

Japan, China
Novo Nordisk A/S

Completed

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment (Start)

Diabetes Mellitus, Type 2 | Diabetes

Finland
University of Aarhus
Aarhus University Hospital; University of Copenhagen; Lundbeck Foundation; Vejle... and other collaborators

Completed

Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders

Obesity | Diabetes Mellitus | Metabolic Syndrome | Hyperlipidemia | Arterial Hypertension

Denmark
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Former Serbia and Montenegro
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes (EFFECTIVE)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Former Serbia and Montenegro
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)

Diabetes Mellitus, Type 2 | Diabetes

Austria
Wockhardt

Completed

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics

Diabetes

United States
Universitat Politècnica de Valéncia
Hospital Clínico Universitario de Valencia

Recruiting

Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge (TAILOR/3)

Type 1 Diabetes

Spain
Novo Nordisk A/S

Completed

Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Argentina, Brazil
Novo Nordisk A/S

Completed

Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes (IMPROVE™)

Diabetes Mellitus, Type 2 | Diabetes

Saudi Arabia, China, India, Iran, Islamic Republic of, Korea, Republic of, Russian Federation, Poland, Japan, Italy, Canada, Greece
Assiut University

Not yet recruiting

Prevalence of IR in Overweight and Obese Adolescents (IR)

Insulin Resistance
Helse Stavanger HF

Completed

Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes

Diabetes Mellitus, Type 1

Norway
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7) (WP7)

Diabetes Mellitus, Type 1 | Closed Loop

France
Geropharm

Completed

Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

Bioequivalence

Russian Federation
Federico II University

Unknown

Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options

Diabetes Mellitus, Type 1

Italy
Novo Nordisk A/S

Completed

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes (UPGRADE)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Korea, Republic of
Federico II University

Terminated

Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward (Initiator)

Diabetes Mellitus | Covid19

Italy
University Hospital, Ghent

Completed

Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

Critically Ill Patients

Belgium
Royal Devon and Exeter NHS Foundation Trust
University of Oxford; Oxford University Hospitals NHS Trust; University of Exeter

Completed

Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes (DIVA-Exeter)

Diabetes Mellitus

United Kingdom
Steno Diabetes Center Copenhagen
Aarhus University Hospital

Recruiting

Automated Insulin Delivery for Type 1 Diabetes - Beyond Glucose Metrics (AID-BEYOND)

Diabetes Mellitus, Type 1

Denmark
Wockhardt

Terminated

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

Type I Diabetes

United States, India
Pfizer
Sanofi

Completed

US Inhaled Insulin Dose Titration Study

Diabetes Mellitus, Type 2

United States
Nanjing First Hospital, Nanjing Medical University

Recruiting

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Wockhardt

Completed

Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects

Diabetes

United States
Charles University, Czech Republic

Recruiting

Android Artificial Pancreas System (Android APS) Versus Control-IQ (CODIAC)

Diabetes Mellitus, Type 1

Czechia
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Diabeloop for Kids (DBL4K)

Diabetes Mellitus, Type 1 | Closed Loop | Young Children (6 to 12 Years Old )

Belgium, France
Sanofi

Completed

Insulin Glargine in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs (IMPROVE)

Diabetes Mellitus, Type 2 | Diabetes

Turkey
Biologics & Biosimilars Collective Intelligence...
Merck Sharp & Dohme LLC; Pfizer; AbbVie; University of Pittsburgh; Boehringer Ingelheim and other collaborators

Completed

Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics

Diabetes
Sanofi

Terminated

LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Hungary
University of Pennsylvania

Recruiting

SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial (SAK)

Heart Failure With Preserved Ejection Fraction

United States
University Hospital Rijeka

Completed

Outcome of Very Preterm Infants With Glucose Level Disturbances

Cerebral Palsy Infantile

Croatia
Novo Nordisk A/S

Completed

Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

Diabetes Mellitus, Type 2 | Diabetes

United States
Wockhardt

Completed

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.

Diabetes

United States
University Medical Centre Ljubljana

Completed

Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis

Acute Pancreatitis

Slovenia
Montefiore Medical Center

Completed

Endothelial Function in Obese Adolescents

Obesity | Atherosclerosis | Insulin Resistance | Glucose Intolerance

United States
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes (EUROMIX)

Diabetes Mellitus, Type 2 | Diabetes

Austria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...

Recruiting

Pancreatic Clamp in NAFLD

Obesity | Insulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver Disease

United States
J.H. DeVries
Rijnstate Hospital; Inreda Diabetic B.V.

Completed

Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, (APPEL5)

Diabetes Mellitus, Type 1

Netherlands
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Mechanisms for Restoration of Hypoglycemia Awareness

Type1 Diabetes Mellitus

United States
Sanofi

Completed

Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s) (Lixilan-O-AP)

Type 2 Diabetes Mellitus

China, Korea, Republic of, Malaysia, Taiwan

Search clinical trials for: Glucose-Insulin-Potassium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations